---
title: "BNP Paribas Exane Upgrades Genmab to Neutral, Cuts PT"
date: "2025-02-11 20:24:04"
summary: "BNP Paribas Exane on Tuesday upgraded Danish healthcare company Genmab  to neutral from underperform and lowered its price target to 1,500 Danish kroner from 2,000 kroner."
categories:
  - "MT Newswires"
lang:
  - "en"
translations:
  - "en"
tags:
  - "MT Newswires"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

BNP Paribas Exane on Tuesday upgraded Danish healthcare company Genmab to neutral from underperform and lowered its price target to 1,500 Danish kroner from 2,000 kroner.

[MT Newswires](https://www.tradingview.com/news/mtnewswires.com:20250211:G2466320:0/)
